Cynapsus Therapeutics Inc. (CYNA)

[Citrati]

Seel, this board is no longer in use and wanted to ask you your feelings on MRNS.
I didn't want to clutter another board or use the MRNS board as I value your independent objectivity.
Selfishly, wanted your input first without opening your thoughts to an entire board if you wanted to keep it more private to begin with.

" a clinical stage biopharmaceutical company, focused on developing and commercializing neuropsychiatric therapeutics. It is developing ganaxolone, a small molecule, which is in Phase III clinical trials to treat patients with refractory focal onset seizures; and is in Phase II clinical trials for the treatment of orphan disease, as well as is in Phase II crossover clinical study to treat behaviors in Fragile X Syndrome, an orphan indication. The company is also developing an IV formulation for use in the hospital setting to control acute seizures. It has a collaboration agreement with NovaMedica, LLC; and license agreement with Purdue Neuroscience Company."
Seems very promising.

PIRS sure looks like it will continue growing.

One I like a lot is NVTR. Just getting started with revenue growth. I think (no promises, lol) it could be around $20 or so within 6 months with potential Q over Q gains. Very small share structure and float.